Product Images Ibu

These are Ibuprofen tablets manufactured by Dr. Raddy's Laboratories and packaged by GSMS, Incorporated. Each tablet contains 400 mg of Ibuprofen, and the package includes 500 tablets. The package insert should be consulted for dosage information. The tablets should be stored at room temperature and kept out of the reach of children. They should be dispensed in a light-resistant container as defined in USP, and the package is not child-resistant.*

These are Ibuprofen Tablets, USP that contain 600 mg of Ibuprofen each. They come in a bottle of 500 tablets and the package insert should be consulted for dosage information. It is important to keep this and all drugs out of reach of children and to store them at room temperature, avoiding excessive heat. The tablets should be dispensed in a tightly sealed, light-resistant container and may require a Medication Guide. It is also noted that the package is not child-resistant. The manufacturer is Dr. Reddy's Laboratories Louisiana LLC, and the product is packaged by GSMS, Incorporated in Camarillo, CA.*

This is a description of Ibuprofen Tablets, USP, containing 800 mg and packaged in 500 tablets. It is recommended to store at room temperature and avoid excessive heat. The package contains information on dosage. Ibuprofen is the active ingredient, and the package warning recommends keeping it out of reach of children. It is dispensed in a tightly closed, light-resistant container, and a Medication Guide is included. The package is not child-resistant. It is manufactured by Dr. Reddy's Laboratories Louisiana LLC, Shreveport, LA 71108 USA, and packaged by GSMS, Incorporated, Gamarillo, CA 93012 USA.*

This text describes the potential side effects and adverse reactions to a medication, organized by bodily system and frequency of occurrence. It notes several possible adverse reactions with a probable causal relationship to the medication, including gastrointestinal issues, central nervous system effects, and hematologic reactions. It also lists reactions that occur in less than 3% of patients and are classified as "Precise Incidence Unknown," as well as those with an unknown causal relationship.*